DrugPatentWatch Database Preview

Astrazeneca Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ASTRAZENECA PHARMS, and when can generic versions of ASTRAZENECA PHARMS drugs launch?

ASTRAZENECA PHARMS has twenty-three approved drugs.

There are seventy-eight US patents protecting ASTRAZENECA PHARMS drugs.

There are one thousand five hundred and thirty-three patent family members on ASTRAZENECA PHARMS drugs in sixty-eight countries and one hundred and thirty-seven supplementary protection certificates in sixteen countries.

Summary for Astrazeneca Pharms

International Patents:	1533
US Patents:	78
Tradenames:	20
Ingredients:	17
NDAs:	23

Drugs and US Patents for Astrazeneca Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Astrazeneca Pharms	NEXIUM	esomeprazole magnesium	FOR SUSPENSION, DELAYED RELEASE;ORAL	021957-003	Dec 15, 2011		RX	Yes	No	6,369,085*PED				Y
Astrazeneca Pharms	LOKELMA	sodium zirconium cyclosilicate	FOR SUSPENSION;ORAL	207078-002	May 18, 2018		RX	Yes	Yes
Astrazeneca Pharms	LYNPARZA	olaparib	TABLET;ORAL	208558-001	Aug 17, 2017		RX	Yes	No
Astrazeneca Pharms	PULMICORT RESPULES	budesonide	SUSPENSION;INHALATION	020929-001	Aug 8, 2000	AN	RX	Yes	No	7,524,834*PED				Y
Astrazeneca Pharms	TUDORZA PRESSAIR	aclidinium bromide	POWDER, METERED;INHALATION	202450-001	Jul 23, 2012		RX	Yes	Yes	6,681,768		Y
Astrazeneca Pharms	TAGRISSO	osimertinib mesylate	TABLET;ORAL	208065-002	Nov 13, 2015		RX	Yes	Yes

Expired US Patents for Astrazeneca Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Astrazeneca Pharms	NEXIUM	esomeprazole magnesium	FOR SUSPENSION, DELAYED RELEASE;ORAL	021957-001	Oct 20, 2006	4,783,974*PED
Astrazeneca Pharms	ALVESCO	ciclesonide	AEROSOL, METERED;INHALATION	021658-003	Jan 10, 2008	6,036,942
Astrazeneca Pharms	PULMICORT RESPULES	budesonide	SUSPENSION;INHALATION	020929-002	Aug 8, 2000	4,787,536*PED
Astrazeneca Pharms	NEXIUM	esomeprazole magnesium	FOR SUSPENSION, DELAYED RELEASE;ORAL	021957-003	Dec 15, 2011	6,875,872*PED
Astrazeneca Pharms	PRILOSEC OTC	omeprazole magnesium	TABLET, DELAYED RELEASE;ORAL	021229-001	Jun 20, 2003	4,786,505*PED
Astrazeneca Pharms	NEXIUM	esomeprazole magnesium	CAPSULE, DELAYED REL PELLETS;ORAL	021153-002	Feb 20, 2001	4,508,905

Paragraph IV (Patent) Challenges for ASTRAZENECA PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	For Injection	20 mg/vial and 40 mg/vial		2009-11-23
	Inhalation Suspension	0.25 mg/2 mL and 0.5 mg/2 mL		2005-09-15
	Delayed-release Capsules	20 mg		2007-03-19
	Tablets	90 mg		2015-07-20
	Tablets	500 mcg		2015-03-02
	Tablets	25 mg		2005-08-12
	Tablets	100 mg, 200 mg and 300 mg		2006-02-21
	Delayed-release for Oral Suspension	2.5 mg and 5 mg		2018-09-24
	Nasal Spray	250 mcg		2012-02-13
	Inhalation Suspension	1 mg/2 mL		2010-05-28
	Delayed-release Tablets	20 mg		2012-03-30
	Tablets	60 mg		2015-09-30
	Tablets	12.5 mg and 25 mg		2018-09-17
	Tablets	50 mg, 150 mg and 400 mg		2007-02-12
	Delayed-release	20 mg and 40 mg		2005-08-05

International Patents for Astrazeneca Pharms Drugs

Country	Patent Number	Estimated Expiration
Estonia	05222
Austria	239011
Cyprus	1118030
South Africa	200209324
Taiwan	I465445
Australia	766618

Supplementary Protection Certificates for Astrazeneca Pharms Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1135391	CA 2011 00013	Denmark		PRODUCT NAME: TICAGRELOR ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF
1259550	08C0052	France		PRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725
0984957	CR 2012 00035	Denmark		PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105
0579826	02C0041	France		PRODUCT NAME: ERTAPENEM SODIUM; REGISTRATION NO/DATE: EU/1/02/216/001 20020418
0984957	122012000017	Germany		PRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812
1694363	27/2015	Austria		PRODUCT NAME: NALOXEGOL, GEGEBENENFALLS IN FORM EINES THERAPEUTISCH VERTRAEGLICHEN SALZES, INSBESONDERE ALS OXALAT; REGISTRATION NO/DATE: EU/1/14/962 20141208

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Astral
• Astrazeneca
• Astrazeneca Ab
• Astrazeneca Lp
• Astrazeneca Pharms